FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James King

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Geographic Areas

Maryland

Phenomena

Cold Temperature

Co-author Network

Publications

TOP 3
James C King; Richard Lichenstein; Laurence S Magder
Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
Richard Lichenstein; Laurence S Magder; Rita Elizabeth King; James C King
The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period.
Virginia Keane; Andrew R Hudson; James C King
Pediatrician attitudes concerning school-located vaccination clinics for seasonal influenza.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James King (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James C King; Richard Lichenstein; Laurence S Magder
Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
Vaccine 2013;31(5):839-44.
2012: Richard Lichenstein; Laurence S Magder; Rita Elizabeth King; James C King
The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period.
The Journal of infectious diseases 2012;206(6):821-7.
2012: Virginia Keane; Andrew R Hudson; James C King
Pediatrician attitudes concerning school-located vaccination clinics for seasonal influenza.
Pediatrics 2012;129 Suppl 2():S96-S100.
2012: Ginny E Cummings; Stephen H Guthrie; Margaret A Hoffmaster; Larry L Leitch; Elizabeth Ruff; James C King
Successful use of volunteers to conduct school-located mass influenza vaccination clinics.
Pediatrics 2012;129 Suppl 2():S88-95.
2012: James C King; Ginny E Cummings; Jonathan Snyder; Dawn Beckett; Bradley S King; Laurence S Magder
Direct and indirect impact of influenza vaccination of young children on school absenteeism.
Vaccine 2012;30(2):289-93.
2011: John J Treanor; Hana El Sahly; Irene Graham; Ruvim Izikson; James C King; Robert Kohberger; Peter Patriarca; Manon Cox
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.
Vaccine 2011;29(44):7733-9.
2010: James C King; Richard Lichenstein; Ginny E Cummings; Laurence S Magder
Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland.
Vaccine 2010;28(49):7737-42.
2009: James C King; Manon M Cox; Keith S Reisinger; James Hedrick; Irene Graham; Peter Patriarca
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
Vaccine 2009;27(47):6589-94.
2008: Mollie M Davis; James C King; Lauren Moag; Ginny E Cummings; Laurence S Magder
Countywide school-based influenza immunization: direct and indirect impact on student absenteeism.
Pediatrics 2008;122(1):e260-5.
2008: Jordana K Schmier; Su Xia Li; James C King; Kristin Nichol; Parthiv Mahadevia
Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
Health affairs (Project Hope) 2008;27(2):w96-104.
2007: James C King; Ginny E Cummings; Nan Guo; Leena Trivedi; Bernard X Readmond; Virginia Keane; Susan Feigelman; Rick de Waard
A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants.
Journal of pediatric gastroenterology and nutrition 2007;44(2):245-51.
2006: James C King; Jeffrey J Stoddard; Manjusha J Gaglani; Kristine A Moore; Laurence S Magder; Elizabeth McClure; Judith D Rubin; Janet A Englund; Kathleen Neuzil
Effectiveness of school-based influenza vaccination.
The New England journal of medicine 2006;355(24):2523-32.
2006: Peter F Wright; Ruth A Karron; Shabir A Madhi; John J Treanor; James C King; Alice O'Shea; Mine R Ikizler; Yuwei Zhu; Peter L Collins; Clare Cutland; Valerie B Randolph; Anne M Deatly; Jill Hackell; William C Gruber; Brian Murphy
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.
The Journal of infectious diseases 2006;193(4):573-81.
2005: James C King; Ginny E Cummings; Jeffrey J Stoddard; Bernard X Readmond; Laurence S Magder; Mary Stong; Margaret Hoffmaster; Judith D Rubin; Theodore Tsai; Elizabeth Ruff
A pilot study of the effectiveness of a school-based influenza vaccination program.
Pediatrics 2005;116(6):e868-73.
2004: Margaret B Rennels; James C King; Robert Ryall; Thomas Papa; James Froeschle
Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
The Pediatric infectious disease journal 2004;23(5):429-35.
2004: Robert B Belshe; Frances K Newman; Theodore F Tsai; Ruth A Karron; Keith S Reisinger; Don Roberton; Helen Marshall; Richard Schwartz; James C King; Frederick W Henderson; William Rodriguez; Joseph M Severs; Peter F Wright; Harry Keyserling; Geoffrey A Weinberg; Kenneth Bromberg; Richard Loh; Peter Sly; Peter McIntyre; John B Ziegler; Jill Hackell; Anne M Deatly; Alice Georgiu; Maribel Paschalis; Shin-Lu Wu; Joanne M Tatem; Brian Murphy; Edwin Anderson
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.
The Journal of infectious diseases 2004;189(3):462-70.
2003: Elizabeth A Helm; Ginny E Cummings; Virginia Keane; James C King
Administration of palivizumab: a medical provider's perspective.
Clinical pediatrics 2003;42(9):821-6.
2003: Sharon Nachman; Soyeon Kim; James C King; Elaine J Abrams; David M Margolis; Ann Petru; William T Shearer; Elizabeth Smith; Jack Moye; Suzette Blanchard; Elizabeth Hawkins; Pamela L Bouquin; Peter Vink; Mindy Benson; Scharla Estep; Frank J Malinoski
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.
Pediatrics 2003;112(1 Pt 1):66-73.
2002: James D Campbell; Robert Edelman; James C King; Thomas Papa; Robert Ryall; Margaret B Rennels
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.
The Journal of infectious diseases 2002;186(12):1848-51.
2002: Margaret B Rennels; James C King; Robert Ryall; Susan Manoff; Thomas Papa; Andrea Weddle; James Froeschle
Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers.
The Pediatric infectious disease journal 2002;21(10):978-9.
2002: Pedro Piedra; Lihan Yan; Karen L Kotloff; Kenneth M Zangwill; David I Bernstein; James C King; John Treanor; Flor M Munoz; Mark Wolff; Iksung Cho; Paul M Mendelman; Julie M Cordova; Robert B Belshe
Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
Pediatrics 2002;110(4):662-72.
2002: Richard Lichenstein; James C King; Judith Lovchik; Virginia Keane
Respiratory viral infections in hospitalized children: implications for infection control.
Southern medical journal 2002;95(9):1022-5.
2002: John P Straumanis; Milagritos D Tapia; James C King
Influenza B infection associated with encephalitis: treatment with oseltamivir.
The Pediatric infectious disease journal 2002;21(2):173-5.
2001: James C King; Patricia Fast; Kenneth M Zangwill; G A Weinberg; Mark Wolff; Lihan Yan; Frances K Newman; Robert B Belshe; Andrea Kovacs; J G Deville; M Jelonek
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
The Pediatric infectious disease journal 2001;20(12):1124-31.
2000: James C King
Influenza vaccines.
Pediatric annals 2000;29(11):692-7.
2000: James C King; William Borkowsky; N Mahidhara; Dace V Madore; E D Shapiro; Richard M Rutstein; T Q Tan; John J Farley; Wayne M Dankner; Sharon Nachman; E Simoes; Patricia M Flynn; John Clemens; Robert G Hamilton
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus.
The Journal of infectious diseases 2000;181(5):1817-21.
2000: Robert B Belshe; William C Gruber; Paul M Mendelman; Hersh Mehta; Kutubuddin Mahmood; Keith S Reisinger; John Treanor; Kenneth M Zangwill; FG Hayden; David I Bernstein; Karen L Kotloff; James C King; Pedro Piedra; S L Block; Lihan Yan; Mark Wolff
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
The Journal of infectious diseases 2000;181(3):1133-7.
2000: James C King; John Treanor; Patricia Fast; Mark Wolff; Lihan Yan; D Iacuzio; Bernard X Readmond; D O'Brien; Kenneth P Mallon; W Edward Highsmith; John S Lambert; Robert B Belshe
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
The Journal of infectious diseases 2000;181(2):725-8.
2000: Robert B Belshe; William C Gruber; Paul M Mendelman; Iksung Cho; Keith S Reisinger; S L Block; Janet Wittes; D Iacuzio; Pedro Piedra; John Treanor; James C King; Karen L Kotloff; David I Bernstein; FG Hayden; Kenneth M Zangwill; Lihan Yan; Mark Wolff
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
The Journal of pediatrics 2000;136(2):168-75.
1998: Robert B Belshe; Paul M Mendelman; John Treanor; James C King; William C Gruber; Pedro Piedra; David I Bernstein; FG Hayden; Karen L Kotloff; Kenneth M Zangwill; D Iacuzio; Mark Wolff
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
The New England journal of medicine 1998;338(20):1405-12.
1998: Richard Lichenstein; James C King; John J Farley; P Su; Prasanna Nair; Peter Vink
Bacteremia in febrile human immunodeficiency virus-infected children presenting to ambulatory care settings.
The Pediatric infectious disease journal 1998;17(5):381-5.
1998: James C King; Rosanna Lagos; David I Bernstein; Pedro Piedra; Karen L Kotloff; M Bryant; Iksung Cho; Robert B Belshe
Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children.
The Journal of infectious diseases 1998;177(5):1394-7.
1998: James C King; Peter Vink; Ih Chang; A Kimura; M Parks; M Smilie; Richard Lichenstein; John J Farley
Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of age.
Vaccine 1998;16(4):361-5.
1997: James C King; Peter Vink; John J Farley; M Smilie; M Parks; Richard Lichenstein
Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection.
Pediatrics 1997;99(4):575-80.
1997: James C King
Community respiratory viruses in individuals with human immunodeficiency virus infection.
The American journal of medicine 1997;102(3A):19-24; discussion 25-6.
1996: Carol Carraccio; P Feinberg; L S Hart; M Quinn; James C King; Richard Lichenstein
Lidocaine for lumbar punctures. A help not a hindrance.
Archives of pediatrics & adolescent medicine 1996;150(10):1044-6.
1996: William C Gruber; Robert B Belshe; James C King; John Treanor; Pedro Piedra; Peter F Wright; George W Reed; E Anderson; F Newman
Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
The Journal of infectious diseases 1996;173(6):1313-9.
1996: James C King; Peter Vink; John J Farley; M Parks; M Smilie; Dace V Madore; Richard Lichenstein; Frank J Malinoski
Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.
The Pediatric infectious disease journal 1996;15(3):192-6.
1995: K L Kale; James C King; John J Farley; Peter Vink; C O Cimino; Peter Paradiso
The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants.
The Pediatric infectious disease journal 1995;14(5):350-4.
1994: John J Farley; James C King; Prasanna Nair; S E Hines; R L Tressler; Peter Vink
Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection.
The Journal of pediatrics 1994;124(6):853-8.
1994: A M Gadomski; Richard Lichenstein; L Horton; James C King; Virginia Keane; T Permutt
Efficacy of albuterol in the management of bronchiolitis.
Pediatrics 1994;93(6 Pt 1):907-12.
1993: Peter Paradiso; DA Hogerman; Dace V Madore; H Keyserling; James C King; Keith S Reisinger; Mark M Blatter; Edward Rothstein; H H Bernstein; J Hackell
Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.
Pediatrics 1993;92(6):827-32.
1993: Richard Lichenstein; James C King; D Bice
Evaluation of chloral hydrate for pediatric sedation.
Clinical pediatrics 1993;32(10):632-3.
1993: James C King; A R Burke; J D Clemens; Prasanna Nair; John J Farley; Peter Vink; S R Batlas; Malla Rao; J P Johnson
Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children.
The Pediatric infectious disease journal 1993;12(9):733-9.
1993: James C King; Richard Lichenstein; Susan Feigelman; C Luna; T J Permutt; J Patel
Measles, mumps, and rubella antibodies in vaccinated Baltimore children.
American journal of diseases of children (1960) 1993;147(5):558-60.
1991: K Midthun; Neal A Halsey; M Jett-Goheen; M L Clements; mark steinhoff; James C King; Ruth A Karron; Modena E H Wilson; B Burns; V Perkis
Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.
The Journal of infectious diseases 1991;164(4):792-6.
1991: Peter F Wright; James C King; K Araki; Y Kondo; Juliette Thompson; Sharon J Tollefson; M Kobayashi; A Z Kapikian
Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
The Journal of infectious diseases 1991;164(2):271-6.
1991: M L Clements; Robert B Belshe; James C King; F Newman; T U Westblom; E L Tierney; W T London; Brian Murphy
Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.
Journal of clinical microbiology 1991;29(6):1175-82.
1991: mark steinhoff; Neal A Halsey; L F Fries; Modena E H Wilson; James C King; B A Burns; R K Samorodin; V Perkis; Brian Murphy; M L Clements
The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.
The Journal of infectious diseases 1991;163(5):1023-8.
1991: Kathryn M Edwards; James C King; mark steinhoff; Juliette Thompson; M L Clements; Peter F Wright; Brian Murphy
Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children.
The Journal of infectious diseases 1991;163(4):740-5.
1990: T Tajima; Juliette Thompson; Peter F Wright; Y Kondo; Sharon J Tollefson; James C King; A Z Kapikian
Evaluation of a reassortant rhesus rotavirus vaccine in young children.
Vaccine 1990;8(1):70-4.
1988: James C King; C J Haugh; W D Dupont; J M Thompson; Peter F Wright; Kathryn M Edwards
Laboratory and epidemiologic assessment of a recent influenza B outbreak.
Journal of medical virology 1988;25(3):361-8.
1987: James C King; Peter A Gross; C R Denning; P F Gaerlan; Peter F Wright; G V Quinnan
Comparison of live and inactivated influenza vaccine in high risk children.
Vaccine 1987;5(3):234-8.
1987: James C King; E D Berman; P F Wright
Evaluation of fever in infants less than 8 weeks old.
Southern medical journal 1987;80(8):948-52.